Deadline: 15 April 2025
The Technology Development Board Department of Science and Technology invites proposals from Indian Companies for development and commercialization of innovative indigenous solutions for Rare and Neglected Tropical Disease Solutions.
Focus Areas
- Rare Diseases
- Orphan Drug Development: Encourage development and commercialization of orphan drugs that target specific rare diseases. Projects demonstrating strong scientific rationale, feasibility, and potential for commercial viability will be prioritized.
- Diagnostic Advancements: Support the creation and commercialization of advanced diagnostic tools and technologies designed for early and accurate detection of rare diseases. Projects that offer practical solutions and demonstrate scalability will be favored.
- Special Medical Diets/Food for Special Medical Purposes (FSMP): Foster the development and commercialization of specialized medical diets tailored to the nutritional requirements of individuals with rare diseases. Emphasis will be placed on projects that offer safe, accessible, and sustainable dietary solutions.
- One-time interventions targeting Group 1 of NPRD 2021: Encourage the development and commercial scale production of medical devices/equipments etc. essential for carrying out groundbreaking one-time treatments or procedures designed to provide lasting or permanent benefits, often addressing the root cause of the disease. These interventions can be life-changing for individuals with rare diseases, where traditional, ongoing treatments may not be feasible or effective.
- Neglected Tropical Diseases
- Immuno and cell-based therapies: Immuno- and cell-based therapies offer promising avenues for tackling neglected diseases, which often afflict populations in resource-limited settings and have historically received inadequate attention and funding. These therapies harness the body’s immune system or utilize specialized cells to combat infectious agents or address underlying disease mechanisms.
Key Features
- Financial Assistance to Indian Companies for Technology Commercialization
- Evaluation on the basis of Scientific, Technological, Financial and Commercial Merit
- Funding shall be in the form of Loan, Equity and/or Grants.
Eligibility Criteria
- Indian Companies (as per Companies Act 1956/2013)
- Start-ups with Recognition Certificate from DPIIT
For more information, visit TDB-DST.
